And Winer

Policy-induced Internal Migration: an Empirical Investigation of the Canadian Case

Q&A: Eric Winer on neoadjuvant clinical trials.

Eric Winer, MD, professor of medicine at Harvard Medical School and director of the Breast Oncology Center at Dana-Farber Cancer Institute, discusses presurgical trials for breast cancer and the roles such trials may eventually play in drug approvals.

WiNER: A Wikipedia Annotated Corpus for Named Entity Recognition

We revisit the idea of mining Wikipedia in order to generate named-entity annotations. We propose a new methodology that we applied to the English Wikipedia to build WiNER, a large, high quality, annotated corpus. We evaluate its usefulness on 6 NER tasks, comparing 4 popular state-of-the art approaches. We show that LSTM-CRF is the approach that benefits the most from our corpus. We report imp...

A Dilated Pore of Winer with Four Openings

Dilated pore was originally designated as a secondary or acquired trichoepithelioma by Winer, represents an appendageal tumor with differentiation towards hair structures. It is clinically characterized by having the appearance of a large blackhead filled with keratinous material. To the best of our knowledge, there has been no report of a dilated pore with four openings. We herein describe suc...

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer

Citation Coates, A. S., E. P. Winer, A. Goldhirsch, R. D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thürlimann, and H.-J. Senn. 2015. “Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.” Annals of Oncology 26 (8): 1533-1546. doi:10.1093/annonc/mdv221. http://dx.doi.org/10.1093/annonc/md...